TipRanks
Verastem (DE:2VSA)
FRANKFURT:2VSA
Germany Market
2VSA
Verastem
RESEARCH TOOLSreports

Verastem (2VSA) Stock News & Sentiment

3 Followers
Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset
Premium
TipRanks Newswire
Nuvectis’ In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It’s Not Even Their Lead Asset
7d ago
AZN
NVS
Verastem: Avutometinib Plus Defactinib Data De-Risk Efficacy Thesis; Buy Rating Reiterated With Unchanged $18 Price Target
Premium
Ratings
Verastem: Avutometinib Plus Defactinib Data De-Risk Efficacy Thesis; Buy Rating Reiterated With Unchanged $18 Price Target
20d ago
VSTM
Verastem Earnings Call Highlights Cash, Pipeline Momentum
Premium
Company Announcements
Verastem Earnings Call Highlights Cash, Pipeline Momentum
2M ago
VSTM
Verastem Restructures Oberland Financing to Support Commercialization
Premium
Company Announcements
Verastem Restructures Oberland Financing to Support Commercialization
2M ago
8K
VSTM
Verastem Reiterated as Buy on Strong AVMAPKI FAKZYNJA Momentum, VS-7375 Progress; $18 Price Target Maintained
Premium
Ratings
Verastem Reiterated as Buy on Strong AVMAPKI FAKZYNJA Momentum, VS-7375 Progress; $18 Price Target Maintained
2M ago
VSTM
Is VSTM a Buy, Before Earnings?
Premium
Pre-Earnings
Is VSTM a Buy, Before Earnings?
2M ago
VSTM
Verastem’s TARGET-D 202 Trial Puts Fresh Focus on KRAS G12D Lung Cancer
Premium
Company Announcements
Verastem’s TARGET-D 202 Trial Puts Fresh Focus on KRAS G12D Lung Cancer
2M ago
VSTM
More DE:2VSA News >

2VSA News on the Web

Verastem (VSTM) CFO Daniel Calkins Sells 55 Shares, Insider Ownership Now at 118,014 Shares
GuruFocus News
Neutral
Stonepine Capital Management, LLC Buys Femasys Inc (FEMY) -- Shares Look 70% Undervalued on GF Value
GuruFocus News
Neutral
Stonepine Capital Management, LLC Expands Edesa Biotech Inc (EDSA) Stake with Strategic Add
GuruFocus News
Neutral
Stonepine Capital Management Expands CalciMedica Stake in Bold Contrarian Move
GuruFocus News
Neutral
Citizens healthcare analysts hold an analyst/industry conference call
TipRanks News
Neutral
Cardiff, Verastem, Fluence, Quantum-Si, Opera Insider Shock
TipRanks News
Bearish
Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), Natera (NTRA) and Vera Therapeutics (VERA)
TipRanks News
Bullish
Top Verastem Executives Quietly Cash Out in Fresh Stock Moves
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
DE:2VSA
Sector Average
Media Buzz
This Week3 articles
Weekly Average2.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:2VSA’s Media Buzz Sentiment?
3 articles about DE:2VSA were published this week. In an average week, 2.5 articles are published.
    What is DE:2VSA’s weekly average amount of articles?
    In an average week, 2.5 articles about DE:2VSA are published.
      What is DE:2VSA’s News Sentiment?
      100% of articles about DE:2VSA were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        HUMHumana
        ACETAdicet Bio
        ZYMEZymeworks
        RHHBYRoche Holding
        QTTBQ32 Bio
        Showing the stocks with the most bullish news sentiment over the past week